Pharmaceutical compositions for the treatment of pain
    12.
    发明申请
    Pharmaceutical compositions for the treatment of pain 有权
    用于治疗疼痛的药物组合物

    公开(公告)号:US20060247304A1

    公开(公告)日:2006-11-02

    申请号:US11115983

    申请日:2005-04-27

    IPC分类号: A61K31/353

    摘要: The present invention relates to treatment of cancer related pain and constipation. Preferably the subject in need is administered a combination of the cannabinoids cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC). More preferably the cannabinoids are in a predefined ratio by weight of approximately 1:1 of CBD to THC.

    摘要翻译: 本发明涉及治疗癌症相关的疼痛和便秘。 优选地,给予大麻素大麻二酚(CBD)和δ-9-四氢大麻酚(THC)的组合。 更优选地,大麻素以CBD的重量约1:1的预定比例与THC。

    CANNABINOIDS FOR USE IN THE TREATMENT OF NEUROPATHIC PAIN
    14.
    发明申请
    CANNABINOIDS FOR USE IN THE TREATMENT OF NEUROPATHIC PAIN 审中-公开
    用于治疗神经性疼痛的CANNABINOIDS

    公开(公告)号:US20120245224A1

    公开(公告)日:2012-09-27

    申请号:US13491077

    申请日:2012-06-07

    IPC分类号: A61K31/352 A61P25/00

    摘要: The present invention relates to the use of cannabidiol (CBD) type compounds or derivative thereof and tetrahydrocannabinol (THC) type compounds or derivative thereof in the manufacture of a medicament for the treatment of neuropathic pain. Preferably, the ratio of the CBD type compounds or derivative thereof and THC type compounds or derivative thereof is between 18:1 and 30:1. More preferably the CBD type compounds or derivative thereof and THC type compounds or derivative thereof are in the form of plant extracts.

    摘要翻译: 本发明涉及大麻二醇(CBD)型化合物或其衍生物和四氢大麻酚(THC)型化合物或其衍生物在制备用于治疗神经性疼痛的药物中的用途。 优选地,CBD型化合物或其衍生物和THC型化合物或其衍生物的比例为18:1至30:1。 更优选CBD型化合物或其衍生物和THC型化合物或其衍生物是植物提取物的形式。

    Pharmaceutical compositions for the treatment of pain
    15.
    发明授权
    Pharmaceutical compositions for the treatment of pain 有权
    用于治疗疼痛的药物组合物

    公开(公告)号:US07968594B2

    公开(公告)日:2011-06-28

    申请号:US11115983

    申请日:2005-04-27

    IPC分类号: A61K31/35 A61K31/07 A61K36/00

    摘要: The present invention relates to treatment of cancer related pain and constipation. Preferably the subject in need is administered a combination of the cannabinoids cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC). More preferably the cannabinoids are in a predefined ratio by weight of approximately 1:1 of CBD to THC.

    摘要翻译: 本发明涉及治疗癌症相关的疼痛和便秘。 优选地,给予大麻素大麻二酚(CBD)和δ-9-四氢大麻酚(THC)的组合。 更优选地,大麻素以CBD的重量约1:1的预定比例与THC。

    NEW USE FOR CANNABINOIDS
    16.
    发明申请
    NEW USE FOR CANNABINOIDS 审中-公开
    新的使用CANNABINOIDS

    公开(公告)号:US20110082195A1

    公开(公告)日:2011-04-07

    申请号:US12863842

    申请日:2009-01-21

    CPC分类号: A61K31/352 A61K31/05

    摘要: The present invention relates to the use of CBD alone or in combination with another cannabinoid, in the manufacture of a pharmaceutical or neutraceutical formulation for use in controlling cholesterol levels in a subject. It also relates to the use of THCV alone or in combination with another cannabinoid, in the manufacture of a pharmaceutical or neutraceutical formulation for use in increasing energy expenditure in a subject. Furthermore the CBD alone or in combination with another cannabinoid or the THCV alone or in combination with another cannabinoid are used as part of a regime to manage or treat type I or II diabetes, obesity, dyslipidaemia, related metabolic disorders and cardiovascular disease.

    摘要翻译: 本发明涉及在制造用于控制受试者中的胆固醇水平的药物或中性制剂中单独使用或与另一种大麻素组合使用。 它还涉及在制造用于增加受试者的能量消耗的药物或中性制剂中单独或与另一种大麻素组合使用THCV。 此外,单独使用CBD或与另一种大麻素或单独使用THCV或与另一种大麻素组合的CBD被用作管理或治疗I型或II型糖尿病,肥胖,血脂异常,相关代谢紊乱和心血管疾病的制度的一部分。

    Cannabinoids for use in the treatment of neuropathic pain
    19.
    发明申请
    Cannabinoids for use in the treatment of neuropathic pain 审中-公开
    大麻素用于治疗神经性疼痛

    公开(公告)号:US20100016418A1

    公开(公告)日:2010-01-21

    申请号:US12308776

    申请日:2007-06-21

    IPC分类号: A61K31/352

    摘要: The present invention relates to the use of cannabidiol (CBD) type compounds or derivative thereof and tetrahydro-cannabinol (THC) type compounds or derivative thereof in the manufacture of a medicament for the treatment of neuropathic pain. Preferably the ratio of the CBD type compounds or derivative thereof and THC type compounds or derivative thereof is between 18:1 and 30:1. More preferably the CBD type compounds or derivative thereof and THC type compounds or derivative thereof are in the form of plant extracts.

    摘要翻译: 本发明涉及大麻二醇(CBD)型化合物或其衍生物和四氢大麻酚(THC)型化合物或其衍生物在制备用于治疗神经性疼痛的药物中的用途。 CBD型化合物或其衍生物和THC型化合物或其衍生物的比例优选为18:1至30:1。 更优选CBD型化合物或其衍生物和THC型化合物或其衍生物是植物提取物的形式。